SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001493152-21-029850
Filing Date
2021-11-24
Accepted
2021-11-24 17:05:05
Documents
12

Document Format Files

Seq Description Document Type Size
1 formdefa14a.htm DEFA14A 44950
2 formdefa14a_001.jpg GRAPHIC 296944
3 formdefa14a_002.jpg GRAPHIC 216793
4 formdefa14a_003.jpg GRAPHIC 231970
5 formdefa14a_004.jpg GRAPHIC 204490
6 formdefa14a_005.jpg GRAPHIC 216299
7 formdefa14a_006.jpg GRAPHIC 230542
8 formdefa14a_007.jpg GRAPHIC 206180
9 formdefa14a_008.jpg GRAPHIC 110464
10 formdefa14a_009.jpg GRAPHIC 235510
11 formdefa14a_010.jpg GRAPHIC 232919
12 formdefa14a_011.jpg GRAPHIC 227450
  Complete submission text file 0001493152-21-029850.txt   3364136
Mailing Address 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ 08852
Business Address 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ 08852 732 545 1590
Advaxis, Inc. (Filer) CIK: 0001100397 (see all company filings)

IRS No.: 841521955 | State of Incorp.: DE | Fiscal Year End: 1031
Type: DEFA14A | Act: 34 | File No.: 001-36138 | Film No.: 211447784
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences